• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Enforcement Report - Week of May 7, 2025.pdf

    FDA

    Enforcement Report - Week of November 6, 2024

    FDA

    Enforcement Report - Week of July 10, 2024

    FDA

    Enforcement Report - Week of April 12, 2023

    FDA

    Enforcement Report - Week of March 8, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-up

    PRNEWSWIRE

    Enforcement Report - Week of February 17, 2021

    FDA

    Accord-UK Ltd Recalls Aripiprazole 1mg/ml oral solution (EL (19)A/20)

    GOVUK

    Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets

    GOV UK

    Enforcement Report - Week of September 19, 2018

    FDA

    Accord Healthcare Voluntarily Recalls Hydrochlorothiazide Tabs Due to Labeling Mix-up

    FDA

    Enforcement Report - Week of February 22, 2017

    FDA

    Accord`s Pregabalin approved in US for Epilepsy

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.